Hangzhou Tianmushan Pharmaceutical Enterprise Co Ltd Class ASSE: 600671

Announcement on Obtaining Notice of Approval for Re-Registration of Drug by Wholly-owned Subsidiary

· Issued by Hangzhou Tianmushan Pharmaceutical Enterprise Co Ltd Class A via Shanghai Stock Exchange
Announcement on Obtaining Notice of Approval for Re-Registration of Drug by Wholly-owned Subsidiary

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference: View Attachment